Article thumbnail

Downregulation in GATA4 and Downstream Structural and Contractile Genes in the db/db Mouse Heart

By Tom L. Broderick, Marek Jankowski, Donghao Wang, Bogdan A. Danalache, Cassandra R. Parrott and Jolanta Gutkowska

Abstract

Reduced expression of GATA4, a transcriptional factor for structural and cardioprotective genes, has been proposed as a factor contributing to the development of cardiomyopathy. We investigated whether the reduction of cardiac GATA4 expression reported in diabetes alters the expression of downstream genes, namely, atrial natriuretic peptide (ANP), B-type natriuretic, peptide (BNP), and α- and β-myosin heavy chain (MHC). db/db mice, a model of type 2 diabetes, with lean littermates serving as controls, were studied. db/db mice exhibited obesity, hyperglycemia, and reduced protein expression of cardiac GLUT4 and IRAP (insulin-regulated aminopeptidase), the structural protein cosecreted with GLUT4. Hearts from db/db mice had reduced protein expression of GATA4 (~35%) with accompanying reductions in mRNA expression of ANP (~40%), BNP (~85%), and α-MHC mRNA (~50%) whereas expression of β-MHC mRNA was increased by ~60%. Low GATA4 was not explained by an increased ligase or atrogin1 expression. CHIP protein content was modestly downregulated (27%) in db/db mice whereas mRNA and protein expression of the CHIP cochaperone HSP70 was significantly decreased in db/db hearts. Our results indicate that low GATA4 in db/db mouse heart is accompanied by reduced expression of GATA4-regulated cardioprotective and structural genes, which may explain the development of cardiomyopathy in diabetes

Topics: Research Article
Publisher: International Scholarly Research Network
OAI identifier: oai:pubmedcentral.nih.gov:3313578
Provided by: PubMed Central

Suggested articles

Citations

  1. (2005). a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardialinfarctioninmice,”AmericanJournalofPhysiology,
  2. (2007). Activity of the β-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism,”
  3. (1998). Al Kawas et al., “Rat heart: a site of oxytocin production and action,”
  4. Atrial natriuretic peptide induces postprandial lipid oxidation in humans,”
  5. (2006). B-Type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higherleftventricularenddiastolicpressures,”AmericanHeart
  6. (2006). Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity,”
  7. (2006). Cardiac-specific deletion of gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability,”
  8. (2004). Cardioprotective functions of atrial natriuretic peptideandB-typenatriureticpeptide:abriefreview,”Clinical andExperimentalPharmacologyandPhysiology,vol.31,no.11,
  9. (2007). Diabetic cardiomyopathy revisited,”
  10. (2007). Diminished GATA4 protein levels contribute to hyperglycemia-induced cardiomyocyte injury,”
  11. (2009). Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy,” J o u r n a lo fP h y s i o l o g y ,
  12. (2003). E.Aasum,A.D.Hafstad,D.L.Severson,andT.S.Larsen,“Agedependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice,”
  13. (1992). Effects of exercise training and diabetes on cardiac myosin heavy chain composition,”
  14. (1986). F i s h e r ,G .G i l l e n ,G .B .M .L i n d o p ,H .J .D a r g i e ,a n d
  15. (2004). Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy,”
  16. (2004). GATA transcription factors in the developing and adult heart,”
  17. (2008). GATA4 is a survivalfactorinadultcardiacmyocytesbutisnotrequiredfor α1A-adrenergic receptor survival signaling,”
  18. (2006). Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure,”
  19. (1984). Hormonal influences on cardiac myosin ATPase activity and myosin isoenzyme distribution,”
  20. (1988). ilson, “The impact of diabetes on survival following myocardial infarction in men vs women.
  21. (2004). Impact of beta-myosin heavy chain expression on cardiac function during stress,” J o u r n a lo ft h e
  22. (1990). Improved post-ischemic ventricular recovery in the absence of changes in energy metabolism in working rat hearts following heat-shock,”
  23. (2004). Inhibitory effect of Ctype natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways,”
  24. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling,”Endocrinology,vol.147,no.9,pp.4160–4168,2006.
  25. (2003). K i m ,K .W .P a r k ,Y .S .K i me ta l . ,“ E ffects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism,”
  26. (1990). Left ventricular functional capacity in the endurancetrained rodent,”
  27. (2009). Less increase of BNP and NT-proBNP levels in obese patient with decompensated heart failure. Interpretation of natriuretic peptides in obesity,”
  28. (1981). Myosin isoenzyme changes in several models of rat cardiac hypertrophy,”
  29. (2008). Nonischemic heart failure in diabetes mellitus,”
  30. (2004). Obesity and suppressed B-type natriuretic peptide levels in heart failure,”
  31. (2010). Oxytocin increases glucose uptake in neonatal rat cardiomyocytes,”
  32. (2008). Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway,” Regulatory Peptides,
  33. (1977). Plasma corticosterone concentrations in diabetic (db)
  34. (2001). Postnatal myosin heavy chain isoformexpressioninnormalmiceandmicenullforIIborIId myosin heavy chains,”
  35. (2001). Prognostic impact of diabetes mellitusISRN Endocrinology 11 in patients with heart failure according to the etiology of left ventricular systolic dysfunction,”
  36. (1997). Regulation of energy substrate metabolism in the diabetic heart,” CardiovascularResearch,vol.34,
  37. (2004). Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase,”
  38. (1989). S c h a ffe r ,M .S .M o z a
  39. (2000). Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction,”
  40. (2001). The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo,”
  41. (2000). The ubiquitinproteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes,”
  42. (2000). The zinc finger-containing transcription factors GATA-4, -5, and -6: ubiquitously expressed regulators of tissue-specific gene expression,”
  43. (2009). Tsujimoto et al., “Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity,”
  44. (2007). Upregulations of Gata4 and oxytocin receptor are important in cardiomyocyte differentiation processes of P19CL6 cells,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.